Gates Package — page 67

e Anticipated February 2015 -- Newlink Genetics will initiate Phase 1 clinical study in U.S. for safety. USG Interagency Coordination e July 18, 2014 = ASPR commissioned a PHEMCE Working Group to provide a landscape of MCMs for treatment and prevention of Ebola and determine which product candidates could be expedited in their development to address the current Ebola outbreaks in West Africa e July 23, 2014 -- PHEMCE Interagency Working Group deliberated on Ebola therapeutics under development e July 25, 2014 -- PHEMCE Interagency Working Group deliberated on Ebola vaccines under development e August 1, 2014 - PHEMCE Interagency Working Group deliberated on how PHEMCE partners can coordinate efforts and develop recommendations for potential use of products e August 6, 2014 - DTRA, NIAID, and BARDA met to discuss development of ZMapp and coordination of efforts o DTRA, NIAID, and BARDA will meet weekly to coordinate efforts and share information e August 2014 -- DTRA, NIAID and BARDA will meet with the FDA under the PHEMCE MOU to ensure that all necessary studies for ZMapp have been completed, are ongoing or planned for IND submission by Mapp Pharmaceutical